Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00125-008-1178-6.

Title:
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors | Diabetologia
Description:
We previously reported that the plasma levels of the endocannabinoid, 2-arachidonoylglycerol (2-AG), in a cohort of viscerally obese men are directly correlated with visceral adipose tissue (VAT) accumulation and metabolic risk factors including low HDL-cholesterol and high triacylglycerol. It is not known, however, if such correlations persist after vigorous lifestyle interventions that reduce metabolic risk factors. We analysed the changes in endocannabinoid levels in a subsample from the same cohort following a 1 year lifestyle modification programme, and correlated them with changes in VAT and metabolic risk factors. Forty-nine viscerally obese men (average age 49 years, BMI 30.9 kg/m2, waist 107.3 cm) underwent a 1 year lifestyle modification programme including healthy eating and physical activity. Plasma levels of 2-AG and the other most studied endocannabinoid, anandamide, were measured by liquid chromatography–mass spectrometry. Anthropometric and metabolic risk factors, including VAT, insulin resistance and glucose intolerance, HDL-cholesterol and triacylglycerol, were measured. Most risk factors were improved by the intervention, which led to a significant decrease in body weight (−6.4 kg, p < 0.0001), waist circumference (−8.0 cm, p < 0.0001) and VAT (−30%, p < 0.0001), and in plasma 2-AG (−62.3%, p < 0.0001) and anandamide (−7.1%, p = 0.005) levels. The decrease in levels of 2-AG but not those of anandamide correlated with decreases in VAT and triacylglycerol levels, and with the increase in HDL3-cholesterol levels. Multivariate analyses suggested that decreases in 2-AG and VAT were both independently associated with decreases in triacylglycerol. This study shows that a strong correlation exists between 2-AG levels and high plasma triacylglycerol and low HDL3-cholesterol in viscerally obese men.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Fitness & Wellness
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,603,974 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💾}

The income method remains a mystery to us.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

levels, insulin, vat, plasma, metabolic, risk, factors, decreases, fasting, article, obese, correlated, hdlcholesterol, glucose, anandamide, variables, endocannabinoid, year, lifestyle, data, men, modification, programme, adipose, high, google, scholar, tissue, obesity, pmoll, resistance, leptin, research, viscerally, accumulation, measured, anthropometric, independent, studies, adiponectin, pubmed, cas, including, marzo, matias, després, visceral, triacylglycerol, study, endocannabinoids,

Topics {✒}

liquid chromatography–mass spectrometry hexokinase–glucose-6-phosphate dehydrogenase method high-sensitivity c-reactive protein high tg–low hdl-cholesterol regular physical activity/exercise antibody-bound peptide hormones particle-enhanced immunonephelometric assays low hdl-cholesterol levels fasting c-peptide levels glucose intolerance-inducing actions independent cross-sectional studies low hdl-cholesterol c-reactive protein ectopic fat accumulation metabolic risk factors privacy choices/manage cookies elevated vat accumulation worse cardiometabolic profile subcutaneous adipose tissue related metabolic abnormalities visceral adipose tissue average age 49 years adipose tissue distribution low hdl3-cholesterol vigorous lifestyle interventions ldl particle size visceral obesity contributes plasma lipoprotein levels metabolic risk factor human abdominal obesity cross-sectional studies [3 related subjects electronic supplementary material type 2 diabetes hdl-cholesterol correlated cb1 receptor activity mannose-binding protein c-peptide aucs overactive endocannabinoid system obese women viscerally obese men european economic area cannabinoid cb1 receptors proposed pro-lipogenic cb1 receptor stimulation healthy eating medical ethics committee b-bridge international highly sensitive immunoassay parametric sign test

Schema {đŸ—ș}

WebPage:
      mainEntity:
         headline:Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
         description:We previously reported that the plasma levels of the endocannabinoid, 2-arachidonoylglycerol (2-AG), in a cohort of viscerally obese men are directly correlated with visceral adipose tissue (VAT) accumulation and metabolic risk factors including low HDL-cholesterol and high triacylglycerol. It is not known, however, if such correlations persist after vigorous lifestyle interventions that reduce metabolic risk factors. We analysed the changes in endocannabinoid levels in a subsample from the same cohort following a 1 year lifestyle modification programme, and correlated them with changes in VAT and metabolic risk factors. Forty-nine viscerally obese men (average age 49 years, BMI 30.9 kg/m2, waist 107.3 cm) underwent a 1 year lifestyle modification programme including healthy eating and physical activity. Plasma levels of 2-AG and the other most studied endocannabinoid, anandamide, were measured by liquid chromatography–mass spectrometry. Anthropometric and metabolic risk factors, including VAT, insulin resistance and glucose intolerance, HDL-cholesterol and triacylglycerol, were measured. Most risk factors were improved by the intervention, which led to a significant decrease in body weight (−6.4 kg, p < 0.0001), waist circumference (−8.0 cm, p < 0.0001) and VAT (−30%, p < 0.0001), and in plasma 2-AG (−62.3%, p < 0.0001) and anandamide (−7.1%, p = 0.005) levels. The decrease in levels of 2-AG but not those of anandamide correlated with decreases in VAT and triacylglycerol levels, and with the increase in HDL3-cholesterol levels. Multivariate analyses suggested that decreases in 2-AG and VAT were both independently associated with decreases in triacylglycerol. This study shows that a strong correlation exists between 2-AG levels and high plasma triacylglycerol and low HDL3-cholesterol in viscerally obese men.
         datePublished:2008-10-30T00:00:00Z
         dateModified:2008-10-30T00:00:00Z
         pageStart:213
         pageEnd:217
         sameAs:https://doi.org/10.1007/s00125-008-1178-6
         keywords:
            Dyslipidaemia
            Endocannabinoids
            HDL-cholesterol
            Insulin resistance
            Obesity
            Type 2 diabetes
            Internal Medicine
            Metabolic Diseases
            Human Physiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-008-1178-6/MediaObjects/125_2008_1178_Fig1_HTML.gif
         isPartOf:
            name:Diabetologia
            issn:
               1432-0428
               0012-186X
            volumeNumber:52
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:V. Di Marzo
               affiliation:
                     name:Consiglio Nazionale delle Ricerche
                     address:
                        name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:M. CĂŽtĂ©
               affiliation:
                     name:HĂŽpital Laval Research Centre
                     address:
                        name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
                     name:Laval University
                     address:
                        name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. Matias
               affiliation:
                     name:Consiglio Nazionale delle Ricerche
                     address:
                        name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                        type:PostalAddress
                     type:Organization
                     name:U862 Centre de Recherche INSERM François Magendie
                     address:
                        name:U862 Centre de Recherche INSERM François Magendie, Bordeaux, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. Lemieux
               affiliation:
                     name:HĂŽpital Laval Research Centre
                     address:
                        name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. J. Arsenault
               affiliation:
                     name:HĂŽpital Laval Research Centre
                     address:
                        name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
                     name:Laval University
                     address:
                        name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. Cartier
               affiliation:
                     name:HĂŽpital Laval Research Centre
                     address:
                        name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
                     name:Laval University
                     address:
                        name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:F. Piscitelli
               affiliation:
                     name:Consiglio Nazionale delle Ricerche
                     address:
                        name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Petrosino
               affiliation:
                     name:Consiglio Nazionale delle Ricerche
                     address:
                        name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. AlmĂ©ras
               affiliation:
                     name:HĂŽpital Laval Research Centre
                     address:
                        name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J.-P. DesprĂ©s
               affiliation:
                     name:HĂŽpital Laval Research Centre
                     address:
                        name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
                     name:Laval University
                     address:
                        name:Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, QuĂ©bec, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
      description:We previously reported that the plasma levels of the endocannabinoid, 2-arachidonoylglycerol (2-AG), in a cohort of viscerally obese men are directly correlated with visceral adipose tissue (VAT) accumulation and metabolic risk factors including low HDL-cholesterol and high triacylglycerol. It is not known, however, if such correlations persist after vigorous lifestyle interventions that reduce metabolic risk factors. We analysed the changes in endocannabinoid levels in a subsample from the same cohort following a 1 year lifestyle modification programme, and correlated them with changes in VAT and metabolic risk factors. Forty-nine viscerally obese men (average age 49 years, BMI 30.9 kg/m2, waist 107.3 cm) underwent a 1 year lifestyle modification programme including healthy eating and physical activity. Plasma levels of 2-AG and the other most studied endocannabinoid, anandamide, were measured by liquid chromatography–mass spectrometry. Anthropometric and metabolic risk factors, including VAT, insulin resistance and glucose intolerance, HDL-cholesterol and triacylglycerol, were measured. Most risk factors were improved by the intervention, which led to a significant decrease in body weight (−6.4 kg, p < 0.0001), waist circumference (−8.0 cm, p < 0.0001) and VAT (−30%, p < 0.0001), and in plasma 2-AG (−62.3%, p < 0.0001) and anandamide (−7.1%, p = 0.005) levels. The decrease in levels of 2-AG but not those of anandamide correlated with decreases in VAT and triacylglycerol levels, and with the increase in HDL3-cholesterol levels. Multivariate analyses suggested that decreases in 2-AG and VAT were both independently associated with decreases in triacylglycerol. This study shows that a strong correlation exists between 2-AG levels and high plasma triacylglycerol and low HDL3-cholesterol in viscerally obese men.
      datePublished:2008-10-30T00:00:00Z
      dateModified:2008-10-30T00:00:00Z
      pageStart:213
      pageEnd:217
      sameAs:https://doi.org/10.1007/s00125-008-1178-6
      keywords:
         Dyslipidaemia
         Endocannabinoids
         HDL-cholesterol
         Insulin resistance
         Obesity
         Type 2 diabetes
         Internal Medicine
         Metabolic Diseases
         Human Physiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-008-1178-6/MediaObjects/125_2008_1178_Fig1_HTML.gif
      isPartOf:
         name:Diabetologia
         issn:
            1432-0428
            0012-186X
         volumeNumber:52
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:V. Di Marzo
            affiliation:
                  name:Consiglio Nazionale delle Ricerche
                  address:
                     name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:M. CĂŽtĂ©
            affiliation:
                  name:HĂŽpital Laval Research Centre
                  address:
                     name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
                  name:Laval University
                  address:
                     name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. Matias
            affiliation:
                  name:Consiglio Nazionale delle Ricerche
                  address:
                     name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                     type:PostalAddress
                  type:Organization
                  name:U862 Centre de Recherche INSERM François Magendie
                  address:
                     name:U862 Centre de Recherche INSERM François Magendie, Bordeaux, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. Lemieux
            affiliation:
                  name:HĂŽpital Laval Research Centre
                  address:
                     name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. J. Arsenault
            affiliation:
                  name:HĂŽpital Laval Research Centre
                  address:
                     name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
                  name:Laval University
                  address:
                     name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. Cartier
            affiliation:
                  name:HĂŽpital Laval Research Centre
                  address:
                     name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
                  name:Laval University
                  address:
                     name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:F. Piscitelli
            affiliation:
                  name:Consiglio Nazionale delle Ricerche
                  address:
                     name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Petrosino
            affiliation:
                  name:Consiglio Nazionale delle Ricerche
                  address:
                     name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. AlmĂ©ras
            affiliation:
                  name:HĂŽpital Laval Research Centre
                  address:
                     name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J.-P. DesprĂ©s
            affiliation:
                  name:HĂŽpital Laval Research Centre
                  address:
                     name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
                  name:Laval University
                  address:
                     name:Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, QuĂ©bec, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Diabetologia
      issn:
         1432-0428
         0012-186X
      volumeNumber:52
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Consiglio Nazionale delle Ricerche
      address:
         name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
         type:PostalAddress
      name:HĂŽpital Laval Research Centre
      address:
         name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
         type:PostalAddress
      name:Laval University
      address:
         name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
         type:PostalAddress
      name:Consiglio Nazionale delle Ricerche
      address:
         name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
         type:PostalAddress
      name:U862 Centre de Recherche INSERM François Magendie
      address:
         name:U862 Centre de Recherche INSERM François Magendie, Bordeaux, France
         type:PostalAddress
      name:HĂŽpital Laval Research Centre
      address:
         name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
         type:PostalAddress
      name:HĂŽpital Laval Research Centre
      address:
         name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
         type:PostalAddress
      name:Laval University
      address:
         name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
         type:PostalAddress
      name:HĂŽpital Laval Research Centre
      address:
         name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
         type:PostalAddress
      name:Laval University
      address:
         name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
         type:PostalAddress
      name:Consiglio Nazionale delle Ricerche
      address:
         name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
         type:PostalAddress
      name:Consiglio Nazionale delle Ricerche
      address:
         name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
         type:PostalAddress
      name:HĂŽpital Laval Research Centre
      address:
         name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
         type:PostalAddress
      name:HĂŽpital Laval Research Centre
      address:
         name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
         type:PostalAddress
      name:Laval University
      address:
         name:Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, QuĂ©bec, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:V. Di Marzo
      affiliation:
            name:Consiglio Nazionale delle Ricerche
            address:
               name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:M. CĂŽtĂ©
      affiliation:
            name:HĂŽpital Laval Research Centre
            address:
               name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
            name:Laval University
            address:
               name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
      name:I. Matias
      affiliation:
            name:Consiglio Nazionale delle Ricerche
            address:
               name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
               type:PostalAddress
            type:Organization
            name:U862 Centre de Recherche INSERM François Magendie
            address:
               name:U862 Centre de Recherche INSERM François Magendie, Bordeaux, France
               type:PostalAddress
            type:Organization
      name:I. Lemieux
      affiliation:
            name:HĂŽpital Laval Research Centre
            address:
               name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
      name:B. J. Arsenault
      affiliation:
            name:HĂŽpital Laval Research Centre
            address:
               name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
            name:Laval University
            address:
               name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
      name:A. Cartier
      affiliation:
            name:HĂŽpital Laval Research Centre
            address:
               name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
            name:Laval University
            address:
               name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
      name:F. Piscitelli
      affiliation:
            name:Consiglio Nazionale delle Ricerche
            address:
               name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
               type:PostalAddress
            type:Organization
      name:S. Petrosino
      affiliation:
            name:Consiglio Nazionale delle Ricerche
            address:
               name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
               type:PostalAddress
            type:Organization
      name:N. AlmĂ©ras
      affiliation:
            name:HĂŽpital Laval Research Centre
            address:
               name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
      name:J.-P. DesprĂ©s
      affiliation:
            name:HĂŽpital Laval Research Centre
            address:
               name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
            name:Laval University
            address:
               name:Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, QuĂ©bec, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
      name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
      name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
      name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
      name:U862 Centre de Recherche INSERM François Magendie, Bordeaux, France
      name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
      name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
      name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
      name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
      name:Department of Anatomy and Physiology, Laval University, QuĂ©bec, Canada
      name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
      name:Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy
      name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
      name:QuĂ©bec Heart Institute, HĂŽpital Laval Research Centre, QuĂ©bec, Canada
      name:Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, QuĂ©bec, Canada

External Links {🔗}(67)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Isotope
  • Prism.js

CDN Services {📩}

  • Crossref

5.28s.